v3.26.1
Unaudited Condensed Consolidated Statements of Operations - USD ($)
3 Months Ended 6 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Mar. 31, 2026
Mar. 31, 2025
Research and development $ 3,145,783 $ 3,932,102 $ 4,489,965 $ 9,648,932
General and administrative 4,073,185 5,164,433 8,153,018 10,391,546
Total operating expenses 7,218,968 9,096,535 12,642,983 20,040,478
Gain on sale of ENTADFI® assets 0 974,303 0 1,669,519
Operating loss from continuing operations (7,218,968) (8,122,232) (12,642,983) (18,370,959)
Non-operating income (expenses):        
Gain on extinguishment of debt 0 0 0 8,624,778
Change in fair value of equity securities 3,931,416 0 3,811,338 (349,078)
Other income, net 195,002 269,839 406,516 432,963
Total non-operating income 4,126,418 269,839 4,217,854 8,708,663
Net loss from continuing operations (3,092,550) (7,852,393) (8,425,129) (9,662,296)
Net income (loss) from discontinued operations, net of taxes 351,418 (49,226) 351,418 (7,184,670)
Net loss $ (2,741,132) $ (7,901,619) $ (8,073,711) $ (16,846,966)
Net loss from continuing operations per basic and diluted common shares and pre-funded warrants outstanding (in dollars per share) $ (0.13) $ (0.54) $ (0.39) $ (0.66)
Net income (loss) from discontinued operations per basic and diluted common shares and pre-funded warrants outstanding (in dollars per share) 0.02 (0) 0.02 (0.49)
Net loss per basic and diluted common shares and pre-funded warrants outstanding (in dollars per share) $ (0.12) $ (0.54) $ (0.37) $ (1.15)
Basic and diluted weighted average common shares and pre-funded warrants outstanding (in shares) 23,050,320 14,638,614 21,655,705 14,638,502

Source